Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

The pharmacokinetic-pharmacodynamic model of azithromycin for lipopolysaccharide-induced depressive-like behavior in mice.

Hao K, Qi Q, Hao H, Wang G, Chen Y, Liang Y, Xie L.

PLoS One. 2013;8(1):e54981. doi: 10.1371/journal.pone.0054981.

2.

Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice.

Ivetić Tkalcević V, Bosnjak B, Hrvacić B, Bosnar M, Marjanović N, Ferencić Z, Situm K, Culić O, Parnham MJ, Eraković V.

Eur J Pharmacol. 2006 Jun 6;539(1-2):131-8.

PMID:
16698012
3.

Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy.

Kang A, Hao H, Zheng X, Liang Y, Xie Y, Xie T, Dai C, Zhao Q, Wu X, Xie L, Wang G.

J Neuroinflammation. 2011 Aug 16;8:100. doi: 10.1186/1742-2094-8-100.

4.

Depressive-like behavior induced by tumor necrosis factor-α in mice.

Kaster MP, Gadotti VM, Calixto JB, Santos AR, Rodrigues AL.

Neuropharmacology. 2012 Jan;62(1):419-26. doi: 10.1016/j.neuropharm.2011.08.018.

PMID:
21867719
5.

Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis.

Meyer M, Huaux F, Gavilanes X, van den Brûle S, Lebecque P, Lo Re S, Lison D, Scholte B, Wallemacq P, Leal T.

Am J Respir Cell Mol Biol. 2009 Nov;41(5):590-602. doi: 10.1165/rcmb.2008-0155OC.

PMID:
19244203
6.

Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains.

Treyaprasert W, Schmidt S, Rand KH, Suvanakoot U, Derendorf H.

Int J Antimicrob Agents. 2007 Mar;29(3):263-70.

PMID:
17194570
7.
8.

Central administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice.

Park SE, Dantzer R, Kelley KW, McCusker RH.

J Neuroinflammation. 2011 Feb 9;8:12. doi: 10.1186/1742-2094-8-12.

9.

Prostaglandins mediate depressive-like behaviour induced by endotoxin in mice.

de Paiva VN, Lima SN, Fernandes MM, Soncini R, Andrade CA, Giusti-Paiva A.

Behav Brain Res. 2010 Dec 20;215(1):146-51. doi: 10.1016/j.bbr.2010.07.015.

PMID:
20654654
10.

Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo.

den Hollander JG, Knudsen JD, Mouton JW, Fuursted K, Frimodt-Møller N, Verbrugh HA, Espersen F.

Antimicrob Agents Chemother. 1998 Feb;42(2):377-82.

11.

Correlation of increased azithromycin concentrations with phagocyte infiltration into sites of localized infection.

Girard AE, Cimochowski CR, Faiella JA.

J Antimicrob Chemother. 1996 Jun;37 Suppl C:9-19.

12.

Influence of immunosuppression on the pharmacokinetics and pharmacodynamics of azithromycin in infected mouse tissues.

Girard D, Regan PA, Milisen WB, Retsema JA, Swindell AC.

J Antimicrob Chemother. 1996 Jun;37 Suppl C:21-35.

13.

Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice.

Legssyer R, Huaux F, Lebacq J, Delos M, Marbaix E, Lebecque P, Lison D, Scholte BJ, Wallemacq P, Leal T.

Respir Res. 2006 Oct 25;7:134.

14.

Central administration of insulin-like growth factor-1 inhibits lipopolysaccharide-induced sickness behavior in mice.

Dantzer R, Gheusi G, Johnson RW, Kelley KW.

Neuroreport. 1999 Feb 5;10(2):289-92.

PMID:
10203323
15.

Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.

Girard D, Finegan SM, Dunne MW, Lame ME.

J Antimicrob Chemother. 2005 Aug;56(2):365-71.

16.

Macrolide antibiotics like azithromycin increase lipopolysaccharide-induced IL-8 production by human gingival fibroblasts.

Kamemoto A, Ara T, Hattori T, Fujinami Y, Imamura Y, Wang PL.

Eur J Med Res. 2009 Jul 22;14(7):309-14.

17.

Chronic blockade of glucocorticoid receptors by RU486 enhances lipopolysaccharide-induced depressive-like behaviour and cytokine production in rats.

Wang D, Lin W, Pan Y, Kuang X, Qi X, Sun H.

Brain Behav Immun. 2011 May;25(4):706-14. doi: 10.1016/j.bbi.2011.01.011.

PMID:
21276847
19.

Alteration of somatotropic function by proinflammatory cytokines.

Frost RA, Lang CH.

J Anim Sci. 2004;82 E-Suppl:E100-109. Review.

20.

Comparative pharmacodynamics of azithromycin and roxithromycin with S. pyogenes and S. pneumoniae in a model that simulates in vitro pharmacokinetics in human tonsils.

Firsov AA, Zinner SH, Vostrov SN, Kononenko OV, Portnoy YA, Shustova LV, Kadenatsi IB.

J Antimicrob Chemother. 2002 Jan;49(1):113-9.

Items per page

Supplemental Content

Support Center